10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234,459 | 274,695 | 312,514 | 588,475 | 600,468 |
| Marketable Securities | 218,435 | 225,546 | 226,836 | N/A | N/A |
| Receivables | 83,549 | 76,204 | 76,526 | 85,254 | 78,430 |
| Inventories | 78,629 | 70,646 | 63,697 | 59,966 | 51,141 |
| TOTAL | $629,422 | $666,232 | $697,335 | $747,591 | $744,104 |
| Non-Current Assets | |||||
| PPE Net | 257,694 | 223,001 | 190,200 | 169,492 | 142,589 |
| Intangibles | 28,004 | 28,639 | 29,275 | 29,908 | 4,511 |
| Other Non-Current Assets | 81,087 | 83,719 | 86,441 | 71,835 | 99,368 |
| TOTAL | $366,785 | $335,359 | $305,916 | $271,235 | $246,468 |
| Total Assets | $996,207 | $1,001,591 | $1,003,251 | $1,018,826 | $990,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,594 | 26,731 | 18,956 | 17,351 | 17,037 |
| Accrued Expenses | 90,203 | 76,727 | 62,419 | 82,535 | 73,369 |
| TOTAL | $126,855 | $117,908 | $94,446 | $110,357 | $100,375 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,665 | 6,473 | 5,434 | 5,340 | 5,505 |
| Other Non-Current Liabilities | 93,560 | 100,167 | 102,120 | 90,901 | 89,976 |
| TOTAL | $93,560 | $100,167 | $102,120 | $90,901 | $89,976 |
| Total Liabilities | $220,415 | $218,075 | $196,566 | $201,258 | $190,351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,464 | 113,914 | 113,372 | 112,845 | 111,708 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,012,106 | -970,192 | -905,734 | -863,321 | -844,872 |
| Other shareholders' equity | -5,492 | -3,965 | -2,443 | 22 | 194 |
| TOTAL | $775,792 | $783,516 | $806,685 | $817,568 | $800,221 |
| Total Liabilities And Equity | $996,207 | $1,001,591 | $1,003,251 | $1,018,826 | $990,572 |